These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 21709191)
1. Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy-induced toxicity? Carnevale-Schianca F; Gallo S; Rota-Scalabrini D; Sangiolo D; Fizzotti M; Caravelli D; Capaldi A; Anselmetti G; Palesandro E; D'Ambrosio L; Coha V; Obert R; Aglietta M; Grignani G J Clin Oncol; 2011 Aug; 29(24):e691-3. PubMed ID: 21709191 [No Abstract] [Full Text] [Related]
2. Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma. Dei-Adomakoh YA; Afriyie-Mensah JS; Gbadamosi H Ghana Med J; 2020 Dec; 54(4):279-283. PubMed ID: 33883778 [TBL] [Abstract][Full Text] [Related]
3. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. Buchler T; Bomanji J; Lee SM Haematologica; 2007 Nov; 92(11):e120-1. PubMed ID: 18024389 [TBL] [Abstract][Full Text] [Related]
4. Control of aggressive fibromatosis by treatment with imatinib mesylate: a step forward? Ravaioli A; Nicoletti S; Tamburini E; Papi M J Cancer Res Clin Oncol; 2009 Feb; 135(2):325-6. PubMed ID: 18825412 [TBL] [Abstract][Full Text] [Related]
5. [Arsenic treatment for leukemia: new model of human cancer target treatment]. Zhao WW; Chen SJ Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545 [No Abstract] [Full Text] [Related]
7. Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis. Yamasawa H; Sugiyama Y; Bando M; Ohno S Respiration; 2008; 75(3):350-4. PubMed ID: 16449804 [TBL] [Abstract][Full Text] [Related]
9. [Effect of imatinib mesylate on bleomycin-induced pulmonary fibrosis in mice]. Li L; Li YQ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):229-32. PubMed ID: 17448279 [TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate for melanoma: will a new target be revealed? Grossman D J Invest Dermatol; 2004 Dec; 123(6):xi-xiii. PubMed ID: 15610499 [No Abstract] [Full Text] [Related]
11. The era of personalized medicine: back to basics. Hutchinson L; DeVita VT Nat Clin Pract Oncol; 2008 Nov; 5(11):623. PubMed ID: 18957968 [No Abstract] [Full Text] [Related]
12. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings. Busalacchi PJ; de la Calle MA; Torroba A; Del Río ST AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023 [No Abstract] [Full Text] [Related]
13. Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate. Abhyankar SA; Nair N Clin Nucl Med; 2008 Mar; 33(3):213-4. PubMed ID: 18287851 [No Abstract] [Full Text] [Related]
14. First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy. Salazar M; Barata A; André S; Venâncio J; Francisco I; Cravo M; Nobre-Leitão C Gut; 2006 Apr; 55(4):585-6. PubMed ID: 16531543 [No Abstract] [Full Text] [Related]
15. Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified. Iurlo A; Fracchiolla NS; Ferla V; Cassin R; Gottardi E; Beghini A; Gianelli U; Spinelli O; Cortelezzi A J Clin Oncol; 2014 Apr; 32(10):e37-9. PubMed ID: 24449233 [No Abstract] [Full Text] [Related]
16. Current management of GISTs. Blanke C Clin Adv Hematol Oncol; 2010 May; 8(5):334. PubMed ID: 20551892 [No Abstract] [Full Text] [Related]
17. Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene. Terheyden P; Houben R; Pajouh P; Thorns C; Zillikens D; Becker JC J Invest Dermatol; 2010 Jan; 130(1):314-6. PubMed ID: 19812602 [No Abstract] [Full Text] [Related]
20. Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene. Yamaguchi M; Matsumoto T; Tate G; Higuchi T J Gastroenterol; 2004 Sep; 39(9):904-5. PubMed ID: 15565413 [No Abstract] [Full Text] [Related] [Next] [New Search]